Health

Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development

Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025:  Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd.…

5 months ago

Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption

July 29, 2025 09:01 ET  | Source: Windtree Therapeutics Investors choose to redeem or convert the majority of Series C…

5 months ago

NewGen Announces Strategic Acquisition of Cytometry Technology and Assets to Support Planned U.S. Expansion

July 29, 2025 09:00 ET  | Source: NewGenIvf Limited The new cytometry technology enhances accessibility, safety, and efficiency in sperm-sorting…

5 months ago

AIM ImmunoTech Announces Pricing of $8.0 Million Public Offering

OCALA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (the “Company”), today announced the pricing…

5 months ago

Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock

Carlsbad, CA, July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), a life sciences company…

5 months ago

Can-Fite Announces Up To $15.0 Million Public Offering

July 28, 2025 12:24 ET  | Source: Can-Fite BioPharma Ltd. $5.0 million upfront with up to an additional $10.0 million…

5 months ago

Floe Health Launches to Power Intelligence at Every Patient Touchpoint

July 28, 2025 12:04 ET  | Source: Floe Health San Francisco, CA, July 28, 2025 (GLOBE NEWSWIRE) -- Floe Health,…

5 months ago

Testosterone Booster for Muscle Gain: Men Opt for OTC Supplement Form Natural Testosterone Replacement Therapy (TRT) Treatment in 2025

New York City, NY, July 27, 2025 (GLOBE NEWSWIRE) -- A recent survey shows that TestoPrime is widely regarded by…

5 months ago

Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia

July 25, 2025 16:05 ET  | Source: atai Life Sciences Initial results demonstrate numerical improvement of cognitive and functional measures…

5 months ago

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

July 25, 2025 16:05 ET  | Source: iRadimed Corporation ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD)…

5 months ago